Learn about DARZALEX FASPRO® + VRd, the latest FDA-approved quad treatment combination for people with newly diagnosed multiple myeloma who are not eligible to receive a stem cell transplant

Sign Up For Support

DARZALEX FASPRO ® is now FDA approved as the first therapy for use alone to treat adults with high-risk smoldering multiple myeloma.

Homepage Banner Desktop Image

Starting treatment

Discover if DARZALEX FASPRO® or DARZALEX® could be right for you

Discover more

PATIENT STORIES

Watch real stories from people who have been treated with DARZALEX FASPRO® or DARZALEX®

Explore the videos
Woman in white shirt and pants walking with man in blue shirt and khaki shortsWoman in white shirt and pants walking with man in blue shirt and khaki shorts